NeuroRPM

NeuroRPM

Private
Washington D.C.Healthcare & Life Scienceshttps://www.neurorpm.com/

Last Round

Accelerator

Sep 19, 2024

Total Funding Raised

$2,500

Company Overview

NeuroRPM is a medtech company that has developed an FDA-cleared, AI-powered remote monitoring application for Parkinson's disease that works with the Apple Watch.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Telemedicine, Medical AI, Health IoT

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Hardware + Subscription

AI Layer

Application

Keywords

Parkinson's disease monitoringremote patient monitoringRPMdigital biomarkersoftware as a medical deviceSaMDclinical trial platformmedical AImotor symptom quantificationdigital therapeuticsDTxwearable health techFDA-cleared softwareApple Watch healthneurodegenerative diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroRPM Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NeuroRPM Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 19, 2024

Key People

Founding team and executive leadership

Chan Lee

Chief Operating Officer

Executive Team

NeuroRPM Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2025

    Monthly visitors grew 63% MoM, reaching 1K.

  • Apr 1, 2025

    Monthly visitors increased 41% MoM.

NeuroRPM Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeuroRPM Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuroRPM's valuation, stock price, and market status.

Firmographic Details

HeadquartersWashington D.C.
Employee Range11
Year Founded2017
Last FundingSep 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.